Published on 25 Nov 2024 on Benzinga · via Yahoo Finance
On Monday, Merck & Co Inc (NYSE:MRK) revealed topline results from the Phase 3 ZENITH study evaluating Winrevair (sotatercept-csrk) in adults with...
Start tracking your investments with Statfolio
Columbia Threadneedle Investments, an investment management company released its “Columbia Divide...
Merck (MRK) announced positive topline results from the Phase 3 ZENITH study evaluating Winrevair...
Winrevair was approved to treat pulmonary arterial hypertension (PAH), a progressive disorder cau...
On Monday, Merck & Co Inc (NYSE:MRK) revealed topline results from the Phase 3 ZENITH study evalu...
We recently compiled a list of the 10 Most Promising Cancer Stocks According to Hedge Funds. In t...
What is Singulair? Singulair, originally sold by Merck & Co., is a prescription drug that was...
We recently made a list of Goldman Sachs’ Top Growth Investors: 34 Stocks With The Highest...
Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks ...
Merck (MRK) has recently been on Zacks.com's list of the most searched stocks. Therefore, you mig...
U.S. government researchers have found that a widely prescribed asthma drug originally sold by Me...